|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.96 USD | -0.96% |
|
-2.92% | +20.17% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.53TCr | 2.03TCr | 2.3TCr | 2.29TCr | 2.22TCr | |||||
Total Revenues | 1.53TCr | 2.03TCr | 2.3TCr | 2.29TCr | 2.22TCr | |||||
Cost of Goods Sold, Total | 1.33TCr | 1.71TCr | 1.87TCr | 1.86TCr | 1.87TCr | |||||
Gross Profit | 201.6Cr | 324.3Cr | 436Cr | 430.1Cr | 348.4Cr | |||||
Selling General & Admin Expenses, Total | 20Cr | 24Cr | 23Cr | 24Cr | 24Cr | |||||
Other Operating Expenses | 7.1Cr | - | 5.1Cr | 14Cr | 26Cr | |||||
Other Operating Expenses, Total | 28Cr | 24Cr | 28Cr | 38Cr | 50Cr | |||||
Operating Income | 174.1Cr | 300.3Cr | 408.3Cr | 392.6Cr | 298.5Cr | |||||
Interest Expense, Total | -53Cr | -49Cr | -48Cr | -45Cr | -44Cr | |||||
Interest And Investment Income | 6Cr | 12Cr | 8.1Cr | 9.7Cr | 8.8Cr | |||||
Net Interest Expenses | -47Cr | -38Cr | -40Cr | -35Cr | -35Cr | |||||
Income (Loss) On Equity Invest. | - | - | - | - | -5Cr | |||||
Currency Exchange Gains (Loss) | - | - | -13Cr | -3.4Cr | - | |||||
Other Non Operating Income (Expenses) | -7.9Cr | -18Cr | -8.4Cr | -16Cr | -10Cr | |||||
EBT, Excl. Unusual Items | 119.3Cr | 244.8Cr | 347.3Cr | 338.4Cr | 247.8Cr | |||||
Restructuring Charges | - | - | - | -6.3Cr | -35Cr | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | 50L | -1.7Cr | |||||
Gain (Loss) On Sale Of Assets | 7.4Cr | - | - | - | - | |||||
Asset Writedown | - | -10Cr | - | -4.9Cr | -34Cr | |||||
Other Unusual Items | -1.5Cr | -24Cr | -11Cr | -4.3Cr | 10L | |||||
EBT, Incl. Unusual Items | 125.2Cr | 211Cr | 336.3Cr | 323.4Cr | 177.1Cr | |||||
Income Tax Expense | -22Cr | 52Cr | 70Cr | 72Cr | 48Cr | |||||
Earnings From Continuing Operations | 146.8Cr | 159.5Cr | 266.2Cr | 251.6Cr | 129.2Cr | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 146.8Cr | 159.5Cr | 266.2Cr | 251.6Cr | 129.2Cr | |||||
Minority Interest | -1.1Cr | -2.3Cr | -2.4Cr | -1.5Cr | -90L | |||||
Net Income - (IS) | 145.7Cr | 157.2Cr | 263.8Cr | 250.1Cr | 128.3Cr | |||||
Net Income to Common Incl Extra Items | 145.7Cr | 157.2Cr | 263.8Cr | 250.1Cr | 128.3Cr | |||||
Net Income to Common Excl. Extra Items | 145.7Cr | 157.2Cr | 263.8Cr | 250.1Cr | 128.3Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.63 | 1.74 | 2.93 | 2.84 | 1.5 | |||||
Basic EPS - Continuing Operations | 1.63 | 1.74 | 2.93 | 2.84 | 1.5 | |||||
Basic Weighted Average Shares Outstanding | 89Cr | 90Cr | 90Cr | 88Cr | 85Cr | |||||
Net EPS - Diluted | 1.63 | 1.73 | 2.92 | 2.83 | 1.5 | |||||
Diluted EPS - Continuing Operations | 1.63 | 1.73 | 2.92 | 2.83 | 1.5 | |||||
Diluted Weighted Average Shares Outstanding | 89Cr | 91Cr | 90Cr | 88Cr | 85Cr | |||||
Normalized Basic EPS | 0.82 | 1.67 | 2.39 | 2.38 | 1.81 | |||||
Normalized Diluted EPS | 0.82 | 1.66 | 2.38 | 2.38 | 1.81 | |||||
Dividend Per Share | 0.18 | 0.48 | 0.64 | 0.68 | 0.68 | |||||
Payout Ratio | 11.05 | 27.67 | 21.83 | 23.99 | 45.13 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 264.5Cr | 394.3Cr | 508.1Cr | 500.5Cr | 412.1Cr | |||||
EBITA | 174.1Cr | 300.3Cr | 408.3Cr | 392.6Cr | 298.5Cr | |||||
EBIT | 174.1Cr | 300.3Cr | 408.3Cr | 392.6Cr | 298.5Cr | |||||
EBITDAR | 294.2Cr | 427.2Cr | 545.1Cr | 539.7Cr | 451.9Cr | |||||
Total Revenues (As Reported) | 1.53TCr | 2.03TCr | 2.3TCr | 2.29TCr | 2.22TCr | |||||
Effective Tax Rate - (Ratio) | -17.25 | 24.41 | 20.84 | 22.2 | 27.05 | |||||
Current Domestic Taxes | 0 | 2.8Cr | 3.3Cr | -10L | 80L | |||||
Current Foreign Taxes | 27Cr | 42Cr | 47Cr | 57Cr | 45Cr | |||||
Total Current Taxes | 27Cr | 44Cr | 50Cr | 57Cr | 46Cr | |||||
Deferred Domestic Taxes | -53Cr | 17Cr | 14Cr | 18Cr | 3.3Cr | |||||
Deferred Foreign Taxes | 4.7Cr | -10Cr | 5.9Cr | -3.1Cr | -1Cr | |||||
Total Deferred Taxes | -49Cr | 7Cr | 20Cr | 15Cr | 2.3Cr | |||||
Normalized Net Income | 73Cr | 150.7Cr | 214.66Cr | 210Cr | 153.98Cr | |||||
Interest on Long-Term Debt | 3.8Cr | 3.8Cr | 4.1Cr | 3.8Cr | 3.1Cr | |||||
Non-Cash Pension Expense | 2.5Cr | 1.4Cr | 3.2Cr | 4.3Cr | 5.7Cr | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 20Cr | 24Cr | 23Cr | 24Cr | 24Cr | |||||
Research And Development Expense From Footnotes | 32Cr | 34Cr | 41Cr | 43Cr | 41Cr | |||||
Net Rental Expense, Total | 30Cr | 33Cr | 37Cr | 39Cr | 40Cr | |||||
Imputed Operating Lease Interest Expense | 12Cr | 13Cr | 16Cr | 16Cr | 16Cr | |||||
Imputed Operating Lease Depreciation | 18Cr | 20Cr | 21Cr | 23Cr | 23Cr | |||||
Stock-Based Comp., Other (Total) | 21Cr | 22Cr | 22Cr | 22Cr | 21Cr | |||||
Total Stock-Based Compensation | 21Cr | 22Cr | 22Cr | 22Cr | 21Cr |
- Stock Market
- Equities
- HAL Stock
- Financials Halliburton Company
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















